Gluceptate Sodium

Gluceptate Sodium

SCHEMBL9319356

O=C([O-])C(O)C(O)C(O)C(O)C(O)CO.[Na+]

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Gluceptate Sodium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.95
PDE4A P27815 1/20 0.64
TDP1 Q9NUW8 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.50
USP2 O75604 1/20 0.48
SLCO1B1 Q9Y6L6 1/20 0.48
KDM4E B2RXH2 2/20 0.37
CA4 P22748 2/20 0.34
OR51E2 Q9H255 1/20 0.33
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014727 1.00 LMNA (0.95) LMNAPDE4ATDP1L3MBTL1USP2
Gluceptate Sodium SCHEMBL147609 1.00 LMNA (0.95) LMNAPDE4ATDP1L3MBTL1USP2
Gluceptate Sodium SCHEMBL29725120 1.00 LMNA (0.95) LMNAPDE4ATDP1L3MBTL1USP2
Gluconic Acid SCHEMBL8607873 1.00 LMNA (0.95) LMNAPDE4ATDP1L3MBTL1USP2
Gluceptate Sodium SCHEMBL11234259 1.00 LMNA (0.95) LMNAPDE4ATDP1L3MBTL1USP2
Gluceptate Sodium SCHEMBL147610 1.00 LMNA (0.95) LMNAPDE4ATDP1L3MBTL1USP2
Gluceptate Sodium SCHEMBL2014725 1.00 LMNA (0.95) LMNAPDE4ATDP1L3MBTL1USP2
Gluceptate Sodium SCHEMBL1479586 1.00 LMNA (0.95) LMNAPDE4ATDP1L3MBTL1USP2
Gluceptate Sodium SCHEMBL11234262 1.00 LMNA (0.95) LMNAPDE4ATDP1L3MBTL1USP2
Gluceptate Sodium SCHEMBL11220711 1.00 LMNA (0.95) LMNAPDE4ATDP1L3MBTL1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117362646-A High Wen Benzheng-resistant ultralow-dielectric polyarylether, foaming material and preparation thereof 潍坊蓉聚材料科技有限公司 2024-01-09 CN claimed
CN-114752942-B Industrial cleaning agent containing gemini structure surfactant and preparation method thereof 泰伦特生物工程股份有限公司 2023-09-22 CN claimed
CN-114349953-B Environment-friendly ether-containing elastomer and preparation method thereof 四川大学 2023-05-05 CN claimed
CN-116041703-A High-whiteness low-impurity-content polyarylether and preparation method thereof 四川大学 2023-05-02 CN claimed
CN-116040683-A Composite manganese oxide and preparation method thereof, and lithium manganate and preparation method thereof 高点(深圳)科技有限公司 2023-05-02 CN claimed
CN-114249894-B Ether-containing polymer containing active group and preparation method and application thereof 四川大学 2022-10-14 CN claimed
CN-111100286-B Green high-purity polyarylether and preparation method thereof 成都锦颜科技有限公司 2022-09-23 CN claimed
CN-114015047-B S-containing polymer and preparation method thereof 四川大学 2022-09-23 CN claimed
CN-114752942-A Industrial cleaning agent containing gemini surfactant and preparation method thereof 泰伦特生物工程股份有限公司 2022-07-15 CN claimed
CN-114349953-A Environment-friendly ether-containing elastomer and preparation method thereof 四川大学 2022-04-15 CN claimed
CN-114249894-A Ether-containing polymer containing active group and preparation method and application thereof 四川大学 2022-03-29 CN claimed
CN-114015047-A S-containing polymer and preparation method thereof 四川大学 2022-02-08 CN claimed
US-20260103806-A1 ALUMINUM CORROSION INHIBITORS FOR CLOSED LOOP SYSTEMS CHEMTREAT, INC. (US) 2026-04-16 US disclosed
US-20260033234-A1 PEROVSKITE SOLAR CELL, PREPARATION METHOD THEREFOR, AND PHOTOVOLTAIC MODULE CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) 2026-01-29 US disclosed
EP-4676196-A1 PEROVSKITE SOLAR CELL, MANUFACTURING METHOD THEREFOR AND PHOTOVOLTAIC MODULE Contemporary Amperex Technology Co., Limited (CN) 2026-01-07 EP disclosed
US-20250368884-A1 FLUID LOSS CONTROL AGENT FOR AQUEOUS WELLBORE FLUIDS SCHLUMBERGER TECHNOLOGY CORP (US) 2025-12-04 US disclosed
CN-112424312-A Salts and chelating agents of monochloroacetic acid for delayed acidification in the oilfield industry 诺力昂化学品国际有限公司 2021-02-26 CN disclosed
US-5318640-A Treating with aqueous solution containing nickel and/or cobalt complex and adjuvants for improved paint adhesion, corrosion resistance HENKEL CORPORATION (US) 1994-06-07 US disclosed
EP-0069718-B1 BASIC ALUMINIUM SULPHATE, ITS MANUFACTURE AND USE Boliden Aktiebolag (SE) 1988-04-27 EP disclosed
EP-0069718-A1 Basic aluminium sulphate, its manufacture and use Boliden Aktiebolag (SE) 1983-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260033234-A1 PEROVSKITE SOLAR CELL, PREPARATION METHOD THEREFOR, AND PHOTOVOLTAIC MODULE CRY1, ALAD, CRY2 LMNA 1562/4885PDE4A 3675/4885TDP1 4694/4885
US-20260103806-A1 ALUMINUM CORROSION INHIBITORS FOR CLOSED LOOP SYSTEMS SLC26A3, SLCO4C1, SLC10A6 LMNA 4572/4885PDE4A 4794/4885TDP1 2523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.